As of 2025-07-13, the Relative Valuation of Prelude Therapeutics Inc (PRLD) is (48.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.81 USD, the upside of Prelude Therapeutics Inc based on Relative Valuation is -6113.3%.
The range of the Relative Valuation is (40.18) - (54.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (40.18) - (54.42) | (48.99) |
| Upside | -5032.3% - -6779.6% | -6113.3% |
| Date | P/E |
| 2025-07-11 | -0.36 |
| 2025-07-10 | -0.39 |
| 2025-07-09 | -0.39 |
| 2025-07-08 | -0.37 |
| 2025-07-07 | -0.36 |
| 2025-07-03 | -0.35 |
| 2025-07-02 | -0.36 |
| 2025-07-01 | -0.36 |
| 2025-06-30 | -0.36 |
| 2025-06-27 | -0.35 |
| 2025-06-26 | -0.38 |
| 2025-06-25 | -0.38 |
| 2025-06-24 | -0.39 |
| 2025-06-23 | -0.37 |
| 2025-06-20 | -0.38 |
| 2025-06-18 | -0.38 |
| 2025-06-17 | -0.41 |
| 2025-06-16 | -0.43 |
| 2025-06-13 | -0.43 |
| 2025-06-12 | -0.46 |
| 2025-06-11 | -0.49 |
| 2025-06-10 | -0.48 |
| 2025-06-09 | -0.52 |
| 2025-06-06 | -0.46 |
| 2025-06-05 | -0.43 |
| 2025-06-04 | -0.44 |
| 2025-06-03 | -0.42 |
| 2025-06-02 | -0.40 |
| 2025-05-30 | -0.39 |
| 2025-05-29 | -0.40 |
| 2025-05-28 | -0.39 |
| 2025-05-27 | -0.35 |
| 2025-05-23 | -0.39 |
| 2025-05-22 | -0.40 |
| 2025-05-21 | -0.41 |
| 2025-05-20 | -0.44 |
| 2025-05-19 | -0.41 |
| 2025-05-16 | -0.39 |
| 2025-05-15 | -0.42 |
| 2025-05-14 | -0.40 |
| 2025-05-13 | -0.44 |
| 2025-05-12 | -0.39 |
| 2025-05-09 | -0.35 |
| 2025-05-08 | -0.36 |
| 2025-05-07 | -0.34 |
| 2025-05-06 | -0.35 |
| 2025-05-05 | -0.36 |
| 2025-05-02 | -0.39 |
| 2025-05-01 | -0.41 |
| 2025-04-30 | -0.43 |